Comparison between the new Xpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.
Published Web Location
https://doi.org/10.1128/spectrum.01647-25
Abstract
Tuberculosis remains a significant global health challenge, with the re-emergence of Mycobacterium tuberculosis (MTB) posing serious concerns, especially in its extra-pulmonary forms. Rapid and accurate diagnosis is crucial for effective management. This study evaluates the performance of the Xpert MTB/RIF Ultra assay compared with the Xpert MTB/RIF and traditional microscopy (Ziehl-Neelsen stain) in diagnosing extra-pulmonary tuberculosis (EPTB) in a tertiary care center in northern India. A total of 100 samples collected from September 2024 to February 2025 underwent testing using these methods. Our findings indicate that the Xpert MTB/RIF Ultra assay demonstrated superior sensitivity and reliability compared with the Xpert MTB/RIF, whereas microscopy was the least effective. This study is the first of its kind in India, highlighting the enhanced diagnostic capabilities of the Xpert MTB/RIF Ultra assay for EPTB.
Importance
This is the first study to come out of India where the newly launched Xpert Ultra/RIF test has been used to detect Paucibacillary EPTB cases in comparison to the old Xpert MTB/RIF test.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.